These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 9377764)

  • 21. Risk factors predicting survival of liver transplantation.
    Matinlauri IH; Nurminen MM; Höckerstedt KA; Isoniemi HM
    Transplant Proc; 2005 Mar; 37(2):1155-60. PubMed ID: 15848655
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Effects of Radix salviae miltiorrhizae on reperfusion injury and hepatocyte apoptosis in donor liver after orthotopic liver transplantation in rats].
    Wang Y; Zhou J; Jiang XQ
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 May; 28(5):870-3. PubMed ID: 18504224
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relevance of donor liver selection and graft viability in a liver transplantation program.
    Mora NP; Turrión VS; Pardo F; Pereira F; Herrera J; Ardaiz J; Olivares P; Murcia J; Vázquez J; Cienfuegos JA
    Transplant Proc; 1988 Oct; 20(5):978-9. PubMed ID: 3055545
    [No Abstract]   [Full Text] [Related]  

  • 24. Biliary inorganic phosphate as a tool for assessing cold preservation-reperfusion injury: a study in the isolated perfused rat liver model.
    Almada LL; Scandizzi AL; Guibert EE; Furno G; Rodriguez JV
    Liver Transpl; 2003 Feb; 9(2):160-9. PubMed ID: 12548510
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of histidine-tryptophan-ketoglutarate solution (HTK) and University of Wisconsin solution (UW) in adult liver transplantation.
    Mangus RS; Tector AJ; Agarwal A; Vianna R; Murdock P; Fridell JA
    Liver Transpl; 2006 Feb; 12(2):226-30. PubMed ID: 16447203
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effects of vascular bed expansion in steatotic rat liver graft viability.
    Astarcioğlu H; Karademir S; Atila K; Sağol O; Koçdor H; Coker A; Astarcioğlu I
    Transpl Int; 2004 May; 17(4):188-94. PubMed ID: 15107972
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Opportunities for scientific expansion of the deceased donor pool.
    Matton AP; Porte RJ
    Liver Transpl; 2014 Nov; 20 Suppl 2():S5. PubMed ID: 25219379
    [No Abstract]   [Full Text] [Related]  

  • 28. Role of reactive metabolites of oxygen and nitrogen in partial liver transplantation: lessons learned from reduced-size liver ischaemia and reperfusion injury.
    Urakami H; Abe Y; Grisham MB
    Clin Exp Pharmacol Physiol; 2007 Sep; 34(9):912-9. PubMed ID: 17645640
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The utility of marginal donors in liver transplantation.
    Busuttil RW; Tanaka K
    Liver Transpl; 2003 Jul; 9(7):651-63. PubMed ID: 12827549
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Birmingham liver unit: use of marginal donors for liver transplantation.
    Starkey G; Buckels J
    Clin Transpl; 2008; ():137-42. PubMed ID: 19708452
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impairment of hepatic mitochondrial respiratory function following storage and orthotopic transplantation of rat livers.
    Sammut IA; Thorniley MS; Simpkin S; Fuller BJ; Bates TE; Green CJ
    Cryobiology; 1998 Feb; 36(1):49-60. PubMed ID: 9500932
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preservation techniques for donors after cardiac death kidneys.
    Wind J; Hoogland ER; van Heurn LW
    Curr Opin Organ Transplant; 2011 Apr; 16(2):157-61. PubMed ID: 21378568
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preconditioning, organ preservation, and postconditioning to prevent ischemia-reperfusion injury to the liver.
    de Rougemont O; Lehmann K; Clavien PA
    Liver Transpl; 2009 Oct; 15(10):1172-82. PubMed ID: 19790166
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Delayed graft function: a frequent but still unsolved problem in renal transplantation].
    Szwarc I; Garrigue V; Delmas S; Deleuze S; Chong G; Mourad G
    Nephrol Ther; 2005 Dec; 1(6):325-34. PubMed ID: 16895703
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Donor graft adenoviral iNOS gene transfer ameliorates rat liver transplant preservation injury and improves survival.
    Kaizu T; Ikeda A; Nakao A; Takahashi Y; Tsung A; Kohmoto J; Toyokawa H; Shao L; Bucher BT; Tomiyama K; Nalesnik MA; Murase N; Geller DA
    Hepatology; 2006 Mar; 43(3):464-73. PubMed ID: 16496305
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relevance of the nutritional status of donors in viability of transplanted hepatic allografts.
    Sankary H; Foster P; Brown E; Bhattachyaryya A; Williams J
    Transplantation; 1992 Jul; 54(1):170-2. PubMed ID: 1631930
    [No Abstract]   [Full Text] [Related]  

  • 37. Increasing the liver donor pool through donation after cardiac death.
    Perkins JD
    Liver Transpl; 2006 Mar; 12(3):487-8. PubMed ID: 16598849
    [No Abstract]   [Full Text] [Related]  

  • 38. Diagnosis and management of allograft failure.
    Burton JR; Rosen HR
    Clin Liver Dis; 2006 May; 10(2):407-35, x. PubMed ID: 16971269
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Randomized trial of Sandostatin prophylaxis for preservation injury after pancreas transplantation.
    Stratta RJ; Taylor RJ; Lowell JA; Bynon JS; Cattral MS; Frisbie K; Brennan DC
    Transplant Proc; 1993 Dec; 25(6):3190-2. PubMed ID: 7505498
    [No Abstract]   [Full Text] [Related]  

  • 40. Impact of donor, technical, and recipient risk factors on survival and quality of life after liver transplantation.
    Moore DE; Feurer ID; Speroff T; Gorden DL; Wright JK; Chari RS; Pinson CW
    Arch Surg; 2005 Mar; 140(3):273-7. PubMed ID: 15781792
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.